SCHEMBL9786655

SCHEMBL9786655

CNC(=S)c1[nH]c(=O)[nH]c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.41
▸ NSD2 O96028 1/20 0.41
▸ ABL1 P00519 1/20 0.41
▸ IDE P14735 1/20 0.41
▸ RIN1 Q13671 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ PDE4A P27815 5/20 0.38
▸ PDE4B Q07343 5/20 0.38
▸ PDE4C Q08493 5/20 0.38
▸ PDE4D Q08499 5/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ PMP22 Q01453 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9786663 0.77 KDM4E (0.32) KDM4E
SCHEMBL9786587 0.71 MAPT (0.50) GAA
SCHEMBL3027360 0.69 GAA (0.55) GAANSD2ABL1IDERIN1
SCHEMBL5419895 0.68 GAA (0.46) GAANSD2ABL1IDERIN1
SCHEMBL29323664 0.67 NSD2 (0.44) GAANSD2ABL1IDERIN1
SCHEMBL9786590 0.67 L3MBTL1 (0.48) GAANSD2ABL1IDERIN1
SCHEMBL10807868 0.65 NSD2 (0.43) GAANSD2ABL1IDERIN1
SCHEMBL9786600 0.64 NSD2 (0.42) GAANSD2ABL1IDERIN1
SCHEMBL10804145 0.64 L3MBTL1 (0.59) GAANSD2ABL1IDERIN1
SCHEMBL9786577 0.64 L3MBTL1 (0.46) GAANSD2ABL1IDERIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5002961-A Antiischemic Agents, Preventing Reperfusion Injuries MERRELL DOW PHARMACEUTICALS (US) 1991-03-26 — — US disclosed
EP-0312960-A2 Method for reducing reperfusion injury with imidazol-2-thione-carboxamides MERRELL DOW PHARMACEUTICALS INC. (US) 1989-04-26 — — EP disclosed
Send feedback